GB9823835D0 - Component for vaccine - Google Patents
Component for vaccineInfo
- Publication number
- GB9823835D0 GB9823835D0 GBGB9823835.5A GB9823835A GB9823835D0 GB 9823835 D0 GB9823835 D0 GB 9823835D0 GB 9823835 A GB9823835 A GB 9823835A GB 9823835 D0 GB9823835 D0 GB 9823835D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- vaccine
- component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9823835.5A GB9823835D0 (en) | 1998-10-30 | 1998-10-30 | Component for vaccine |
JP2000579253A JP2002528517A (en) | 1998-10-30 | 1999-10-27 | Vaccine components |
PCT/GB1999/003559 WO2000025814A2 (en) | 1998-10-30 | 1999-10-27 | Component for vaccine against serogroup b meningococci |
EP99951011A EP1124574A2 (en) | 1998-10-30 | 1999-10-27 | Component for vaccine against serogroup b meningococci |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9823835.5A GB9823835D0 (en) | 1998-10-30 | 1998-10-30 | Component for vaccine |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9823835D0 true GB9823835D0 (en) | 1998-12-23 |
Family
ID=10841614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9823835.5A Ceased GB9823835D0 (en) | 1998-10-30 | 1998-10-30 | Component for vaccine |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1124574A2 (en) |
JP (1) | JP2002528517A (en) |
GB (1) | GB9823835D0 (en) |
WO (1) | WO2000025814A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0024200D0 (en) * | 2000-10-03 | 2000-11-15 | Smithkline Beecham Sa | Component vaccine |
GB0106315D0 (en) * | 2001-03-14 | 2001-05-02 | Ich Productions Ltd | Transfection complexes |
EP1554305B1 (en) * | 2002-10-23 | 2007-03-28 | Centre for Research and Technology Hellas/Institute of Agrobiotechnology | Prion protein-binding peptide sequences |
GB0718966D0 (en) * | 2007-09-28 | 2007-11-07 | Liverpool School Of Tropical M | Bacterial vaccine |
KR20200142010A (en) * | 2018-03-16 | 2020-12-21 | 조에티스 서비시즈 엘엘씨 | Peptide vaccine against interleukin-31 |
JPWO2021162054A1 (en) * | 2020-02-10 | 2021-08-19 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9611673D0 (en) * | 1996-06-05 | 1996-08-07 | Peptide Therapeutics Ltd | Meningococcal vaccine |
JP4150082B2 (en) * | 1996-08-27 | 2008-09-17 | カイロン コーポレイション | Monoclonal antibodies defining unique meningococcal B epitopes and their use in the preparation of vaccine compositions |
-
1998
- 1998-10-30 GB GBGB9823835.5A patent/GB9823835D0/en not_active Ceased
-
1999
- 1999-10-27 WO PCT/GB1999/003559 patent/WO2000025814A2/en not_active Application Discontinuation
- 1999-10-27 JP JP2000579253A patent/JP2002528517A/en not_active Withdrawn
- 1999-10-27 EP EP99951011A patent/EP1124574A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
JP2002528517A (en) | 2002-09-03 |
WO2000025814A2 (en) | 2000-05-11 |
WO2000025814A3 (en) | 2000-07-27 |
EP1124574A2 (en) | 2001-08-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9806456D0 (en) | Vaccine composition | |
GB9812613D0 (en) | Vaccine | |
HUP0105392A3 (en) | Enhanced vaccines | |
GB9822714D0 (en) | Vaccines | |
IL139467A0 (en) | Vaccine | |
GB2337549B (en) | Retaining components | |
GB9801870D0 (en) | Vaccine composition | |
GB9823835D0 (en) | Component for vaccine | |
GB9930591D0 (en) | Component for vaccine | |
GB9930585D0 (en) | Component for vaccine | |
GB9807805D0 (en) | Vaccine | |
GB9820956D0 (en) | Vaccine | |
GB9821821D0 (en) | Schistomiasis vaccine | |
GB9802544D0 (en) | Vaccine | |
GB9822712D0 (en) | Vaccine | |
GB9812228D0 (en) | Vaccine | |
GB9805958D0 (en) | Vaccine | |
GB9811954D0 (en) | Vaccine | |
GB9807933D0 (en) | Vaccine | |
GB9806765D0 (en) | Vaccine | |
GB9805962D0 (en) | Vaccine | |
GB9822709D0 (en) | Vaccine | |
GB9802650D0 (en) | Vaccine | |
GB9805960D0 (en) | Vaccine | |
GB9828035D0 (en) | Vaccine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |